Literature DB >> 15377643

Metabolic activation of AMP kinase in vascular smooth muscle.

L J Rubin1, L Magliola, X Feng, A W Jones, C C Hale.   

Abstract

AMP-activated kinase (AMPK) is a highly conserved heterotrimeric kinase that functions as a metabolic master switch to coordinate cellular enzymes involved in carbohydrate and fat metabolism that regulate ATP conservation and synthesis. AMPK is activated by conditions that increase AMP-to-ATP ratio, such as exercise and metabolic stress. In the present study, we probed whether AMPK was expressed in vascular smooth muscle and would be activated by metabolic stress. Endothelium-denuded porcine carotid artery segments were metabolically challenged with 2-deoxyglucose (10 mM) plus N(2) (N(2)-2DG). These vessels exhibited a rapid increase in AMPK activity by 1 min that was near maximal by 20 min. AMPK inactivation on return to normal physiological saline was approximately 50% in 1 min and fully recovered by 5 min. Immunoprecipitation of the alpha(1)- and alpha(2)-catalytic subunit followed by immunoblot analysis for [P]Thr(172)-AMPK indicates that alpha(1)-AMPK accounts for all activity. Little if any alpha(2)-AMPK was detected in carotid smooth muscle. AMPK activity was not increased by contractile agonist (endothelin-1) or by the reported AMPK activators 5-aminoimidazole-4-carboxamide ribofuranoside (2 mM), metformin (2 mM), or phenformin (0.2 mM). AMPK activation by N(2)-2DG was associated with a rapid and pronounced reduction in endothelin-induced force and reduced phosphorylation of Akt and Erk 1/2. These data demonstrate that AMPK expression differs in vascular smooth muscle compared with striated muscles and that activation and inactivation after metabolic stress occur rapidly and are associated with signaling pathways that may regulate smooth-muscle contraction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377643     DOI: 10.1152/japplphysiol.00075.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  36 in total

1.  AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism.

Authors:  Joshua D Stone; Andrew W Holt; Jackson R Vuncannon; Jeffrey J Brault; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

2.  Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR.

Authors:  Rudolf Pullmann; Magdalena Juhaszova; Isabel López de Silanes; Tomoko Kawai; Krystyna Mazan-Mamczarz; Marc K Halushka; Myriam Gorospe
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

3.  Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3.

Authors:  Ho-Jin Koh; David E Arnolds; Nobuharu Fujii; Thien T Tran; Marc J Rogers; Niels Jessen; Yangfeng Li; Chong Wee Liew; Richard C Ho; Michael F Hirshman; Rohit N Kulkarni; C Ronald Kahn; Laurie J Goodyear
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

4.  Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.

Authors:  Françoise Goirand; Myriam Solar; Yoni Athea; Benoit Viollet; Philippe Mateo; Dominique Fortin; Jocelyne Leclerc; Jacqueline Hoerter; Renée Ventura-Clapier; Anne Garnier
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

5.  Association of AMP-activated protein kinase subunits with glycogen particles as revealed in situ by immunoelectron microscopy.

Authors:  Moise Bendayan; Irene Londono; Bruce E Kemp; Grahame D Hardie; Neil Ruderman; Marc Prentki
Journal:  J Histochem Cytochem       Date:  2009-07-06       Impact factor: 2.479

6.  Acute activation of endothelial AMPK surprisingly inhibits endothelium-dependent hyperpolarization-like relaxations in rat mesenteric arteries.

Authors:  Hui Chen; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

Review 7.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

8.  PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.

Authors:  Wenjuan Li; Joan Liu; Yunfeng Zhao
Journal:  Mol Carcinog       Date:  2012-12-19       Impact factor: 4.784

Review 9.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

10.  Metabolic regulation of neuronal plasticity by the energy sensor AMPK.

Authors:  Wyatt B Potter; Kenneth J O'Riordan; David Barnett; Susan M K Osting; Matthew Wagoner; Corinna Burger; Avtar Roopra
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.